Effective-Component Compatibility of Bufei Yishen Formula III Protects Lung Air-Blood Barrier by Regulating the Oxidative Stress: via the Nuclear Factor-E2-Related Factor 2 Pathway
ECC-BYF III protects lung air-blood barrier in COPD by regulating oxidative stress via Nrf2 pathway.
Authors
- Ruilong Lu
- Zhiguang Qiu (ORCID: https://orcid.org/0000-0002-6198-1100)
- Yixi Liao (ORCID: https://orcid.org/0000-0002-3795-0021)
- Xuejie Shao
- Yange Tian (ORCID: https://orcid.org/0000-0002-5849-4504)
- Kexin Xu
- Bo Wang (ORCID: https://orcid.org/0000-0003-1029-3954)
- Yakun Zhao
Institutions
- First Affiliated Hospital of Henan University (CN)
Publication Details
- Journal
- International Journal of COPD
- Published
- 2025-07-01
- DOI
- https://doi.org/10.2147/copd.s513071
- Citations
- 1
- Primary Topic
- Pharmacological Effects of Natural Compounds
- Type
- article
- Field-Weighted Citation Impact
- 1.56